CSIMarket
 
Bellerophon Therapeutics inc  (NASDAQ: BLPH)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 12
 Employees 45
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 0

Business Description


Bellerophon Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative treatments for cardiopulmonary diseases. The company's main product candidate is INOpulse®, a proprietary pulsatile nitric oxide delivery system designed to improve a patient's quality of life. INOpulse® is currently being evaluated in multiple clinical trials for various indications, including pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Bellerophon Therapeutics aims to address unmet medical needs in the field of cardiopulmonary diseases and improve patient outcomes through its therapeutic solutions.


   Company Address: 20 Independence Boulevard Warren, 7059 NJ
   Company Phone Number: 574-4770   Stock Exchange / Ticker: NASDAQ BLPH


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ICPT        0.21% 
IRWD   -7.58%    
REGN   -7.13%    
SRPT   -11.2%    
SUPN   -4.5%    
VRTX   -8.07%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 4.88
Working Capital Ratio 5.41
Leverage Ratio (MRQ) 0.25
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.84 $
Revenues (TTM) 0.47 $
Cash Flow (TTM) -
Cash 0.37 $
Book Value 0.3 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -205,622
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.